Blogs

The cancer experts at OHC want their patients to enjoy the holiday season with their families and friends, so they’re providing some suggestions to make the holidays easier and more enjoyable for your loved one with cancer. The holidays can wear   (Read More)

One of the most beautiful aspects of Thanksgiving is that it reminds us to think about the people in our lives and the intangible gifts they give us throughout the year. At OHC, we have the privilege to care for our patients and their families, and   (Read More)

It was July 2004 and Nancy Price was celebrating her 50th birthday with family, friends, and co-workers. Just before her birthday, Nancy’s husband made her promise that she would get a good check-up. “I thought it was odd,” said Nancy. “There   (Read More)

The cancer experts at OHC understand that sometimes a cancer patient may need more in-depth support or assistance to address their physical, emotional and social needs. For these patients, OHC offers a new Supportive Care Program to help them manage   (Read More)

November is National Family Caregivers Month and OHC would like to acknowledge these special people who devote their lives to the care and support of a family member or loved one. The American Association of Retired Persons (AARP) estimates that more   (Read More)

Following their ongoing commitment to provide patients with the latest treatment options, doctors at OHC are evaluating another new treatment option for patients diagnosed with acute myeloid leukemia (AML). This treatment is for AML patients who are   (Read More)

OHC’s David M. Waterhouse, MD, MPH, is leading a national clinical trial as the principal investigator to evaluate a new treatment option for patients whose advanced non-small cell lung cancer has not responded to chemotherapy or immunotherapy   (Read More)

At OHC, our cancer doctors want to be able to tell every patient their cancer is in remission, and for patients with pancreatic cancer, that is a special gift. While pancreatic cancer survival rates have been improving over the last several   (Read More)

OHC is leading the way in the fight against breast cancer by assessing every new OHC breast cancer patient against national guidelines that will determine if they should seek genetic testing for mutations. It’s important for patients to know this   (Read More)

OHC, the region’s leading cancer experts, has opened two new clinical trials to evaluate an expanded use of the ground-breaking treatment, chimeric antigen receptor T-cell therapy (CAR-T), making this life-changing treatment available to more   (Read More)

OHC is evaluating a new treatment option for triple negative breast cancer through its clinical trials program. The results of the trial may provide new hope for women diagnosed with this aggressive form of breast cancer. Triple-negative breast   (Read More)

New research has just been published showing promising results for patients with non-small cell lung cancer (NSCLC) five years after treatment. Historically, NSCLC has been universally considered a fatal disease. Patients with stage 4 NSCLC who were   (Read More)

OHC is a leader in the development of a promising new treatment that is being studied in a new clinical trial for adult acute myeloid leukemia (AML). AML is the most common type of acute leukemia in adults and can progress quickly if not treated   (Read More)

September is Ovarian Cancer Awareness Month. OHC is participating in a clinical trial that is evaluating rucaparib (a targeted drug) in combination with nivolumab (an immunotherapy drug) as a maintenance therapy in patients with newly diagnosed   (Read More)

If you are a man, you’re probably somewhat concerned about prostate cancer since it’s the second most common cancer among men in the United States. If you are diagnosed with prostate cancer, our team of cancer experts at OHC can help you with a   (Read More)